Fed. Circ. Backs Sanofi Cancer Drug IP Win, Delaying Generic
A Delaware federal court rightly upheld two patents covering Genzyme's cancer medication Mozobil and stopped Zydus from moving forward with a generic version, the Federal Circuit said Friday....To view the full article, register now.
Already a subscriber? Click here to view full article